CLYM

Climb Bio, Inc. CLYM

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$734.35M total
RA CAPITAL MANAGEMENT, L.P.
$147.36M0.0%
FMR LLC
$88.55MNew
UBS Group AG
$44.40M+3861.7%
BRAIDWELL LP
$36.48M+82.9%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$32.68MNew
BlackRock, Inc.
$30.71M+486.3%
PRICE T ROWE ASSOCIATES INC /MD/
$27.74M+11.0%
Cormorant Asset Management, LP
$27.46MNew
FRONTIER CAPITAL MANAGEMENT CO LLC
$25.28MNew
VANGUARD CAPITAL MANAGEMENT LLC
$22.15M+44.1%
Woodline Partners LP
$20.63MNew
CITADEL ADVISORS LLC
$16.93M+275.5%
Redmile Group, LLC
$15.99MNew
GREAT POINT PARTNERS LLC
$13.04M-25.0%
Affinity Asset Advisors, LLC
$12.67M+38.9%
MILLENNIUM MANAGEMENT LLC
$11.84M-28.8%
ADAR1 Capital Management, LLC
$10.73M+37.6%
DRIEHAUS CAPITAL MANAGEMENT LLC
$10.30M+31.5%
GEODE CAPITAL MANAGEMENT, LLC
$10.20M+149.9%
StemPoint Capital LP
$9.69MNew
STATE STREET CORP
$8.96M+420.3%
AMERIPRISE FINANCIAL INC
$8.58MNew
Parkman Healthcare Partners LLC
$7.35MNew
SUPERSTRING CAPITAL MANAGEMENT LP
$6.79M+161.6%
SPHERA FUNDS MANAGEMENT LTD.
$6.31M+15.4%
See all 109 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CLYM

Earnings Per Share

13fpro.ai/company/CLYM

Loading ratio trend…

CLYM insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Climb Bio, Inc. (CLYM): stock profile, AI score and financials

Climb Bio, Inc. (CLYM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CLYM is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. CLYM trades on the Nasdaq exchange and files with the SEC under CIK 1768446. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CLYM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Climb Bio, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1768446 →